Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 05/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Radius Health, Inc.
*MAILING ADDRESS
22 Boston Wharf Road, 7th Floor
*CITY
Boston
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02210
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations for use in the treatment of connective tissue diseases, inflammatory diseases, blood diseases and hormonal
disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging;
Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, gynecological
diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine
diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive
disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and
trauma
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
009
*IDENTIFICATION
Downloadable written articles in the field of osteoporosis and breast cancer research
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Pharmaceutical research and development; testing of pharmaceuticals
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
044
*IDENTIFICATION
Providing educational information on the use of pharmaceuticals
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Nicholas B. Hawkins
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Womble Bond Dickinson (US) LLP
STREET
100 Light Street, 26th Floor
CITY
Baltimore
STATE
Maryland
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
21202
PHONE
410-545-5827
EMAIL ADDRESS
tmdocketing@wbd-us.com
OTHER APPOINTED ATTORNEY
Peter B. Bromaghim, Carla H. Clements, Melissa G. Ferrario, Anne C. Fleeson, William S. Fultz, Jack B. Hicks, Timothy H. Hiebert, Sarah Anne
Keefe, Laura A. Kees, Kelli A. Ovies, Randel S. Springer, Michael A. Tobin, Emily Scheible Whittaker, Jeffrey S. Whittle
Approved for use through 05/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90764757
Filing Date:06/09/2021
To the Commissioner for Trademarks:
MARK: RADIUS (Standard Characters, see mark)
The literal element of the mark consists of RADIUS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Radius Health, Inc., a corporation of Delaware, having an address of
22 Boston Wharf Road, 7th Floor
Boston, Massachusetts 02210
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations for use in the treatment of connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical
preparations for use in oncology; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical
preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, gynecological diseases,
rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases,
intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood
disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 009: Downloadable written articles in the field of osteoporosis and breast cancer research
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: Pharmaceutical research and development; testing of pharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 044: Providing educational information on the use of pharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Nicholas B. Hawkins. Other appointed attorneys are Peter B. Bromaghim, Carla H. Clements, Melissa G. Ferrario, Anne C. Fleeson, William S. Fultz,
Jack B. Hicks, Timothy H. Hiebert, Sarah Anne Keefe, Laura A. Kees, Kelli A. Ovies, Randel S. Springer, Michael A. Tobin, Emily Scheible Whittaker, Jeffrey S. Whittle. Nicholas B. Hawkins of
Womble Bond Dickinson (US) LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
100 Light Street, 26th Floor
Baltimore, Maryland 21202
United States
410-545-5827(phone)
tmdocketing@wbd-us.com
Nicholas B. Hawkins submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1400 has been submitted with the application, representing payment for 4 class(es).
Declaration
Declaration Signature
Signature: /James harrington/ Date: 06/09/2021
Signatory's Name: James Harrington
Signatory's Position: Chief IP Counsel
Signatory's Phone Number: 4844777804
Signature method: Sent to third party for signature
Payment Sale Number: 90764757
Payment Accounting Date: 06/09/2021
Serial Number: 90764757
Internet Transmission Date: Wed Jun 09 17:58:31 ET 2021
TEAS Stamp: USPTO/BAS-XX.XX.X.XX-2021060917583104645
9-90764757-7804da051da10735ffd82beab9282
fbd9f2eb3eb8eac83906ca184c413cbae48-DA-5
8301078-20210609113245038314